A multi-institutional group has identified a “signature” of metabolic molecules associated with exercise-induced physiologic deficits that, when released into the bloodstream, signal heightened heart failure risk.

The award recognizes individuals who demonstrate “outstanding promise” in physiological sciences research.

New study suggests that treating patients for CHIP (clonal growth of precancerous blood cells) could reduce their risk of potentially life-threatening heart inflammation.

The findings could suggest ways to intervene before clinical symptoms of memory and cognitive impairment become apparent.

Study supports the potential benefits of screening patients for CHIP before they undergo cancer treatment so they can be more closely monitored for heart complications.

The findings could lead to new treatments for blood cancers, which kill an estimated 23,540 people in the United States every year.

The distinction places her among the top 0.05% of scholars worldwide in her specialty, hypertension.